Skip to main content
Main menu
Members
Membership
Membership Directory
Join
Renew
40 under 40 Program
Update Profile
Diversity & Inclusion Working Group
Member Resources
ABI Blog Exchange
Law
Veterans Task Force
St. John's Case Blog
image
Education & Events
Education
Restructuring Masterclass
Bookstore
E-learning
Eye On Bankruptcy
Track your CLE/CPE
Events
Calendar of Events
Call for Abstracts
Conference Materials
Sponsors & Exhibitors
ABI Events App
Newsroom
News
Rochelle Daily Wire
Headlines
Legislative News
Press Releases
Puerto Rico In Distress
Statistics
Supreme Court
Insolvency Informer
SBRA
ABI Journal
Latest Issues
Advertise
Archived Articles
Journal Authors
Journal Columns
Journal Topics
ABI Journal App
Submission Guidelines and Deadlines
Subscribe to ABI Journal
ABI Media
Podcasts
Videos
ABI International
ABI International
Global Insolvency
ABI International Board Committee
About
About ABI
Partners
Annual Reports
Career Opportunities
Contact Us
Login
User account menu
Login
Log in
How Bankrupt Pa. Drug Firm Endo Could Earn $265 Million on an ‘Exceptionally Powerful Opioid’ It Removed Twice from Market
Home
Newsroom
21
June
2025
Article Tags
Claims
Bankruptcy Litigation
Corporate Governance
Court Administration
Creditors' Committee
Business Reorganization
Health Care
Mass Torts
Please note that in order to view the content for the
Bankruptcy Headlines
you must either
Sign in
if you are already an ABI member, or otherwise you may
Become an ABI Member
